Brind.

Europe Faces Widespread Drug Shortages Due to Production Limitations

Steady: 1 in the last 7 days Updated saturday

The latest in this situation

  1. Shortage impact felt across Asia and Europe, with German manufacturer halting insulin supplies.
  2. Bidafarma reported supply issues in Malaga, Spain on October 15, 2026.

How it started

2 reports, 2 independent, last reported Sat 00:00. The briefing below covers this first event.

AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Drug shortages are widespread across Europe, affecting common medicines such as painkillers and blood pressure medication. The European Medicines Agency noted a long-term shortage of Creon due to production limitations and high demand. Separately, an insulin shortage in Pakistan was linked to a German manufacturer halting supplies, an issue whose impact was also noted in Europe.

From tribune.com.pk, gazettelive.co.uk

Why it matters

Some supportBrind's analysis of the reports

The lack of available medicines poses a serious risk to patient safety, according to the National Pharmacy Association. The European Medicines Agency is monitoring these supply issues, which may continue well into 2027 for certain drugs like Creon.

From gazettelive.co.uk

Who's involved

  • European Medicines AgencyMonitors drug shortages and production limitations in Europe.
  • EuropeThe region experiencing widespread drug shortages.
  • CreonA drug facing a long-term Europe-wide shortage due to production capacity issues.
  • National Pharmacy AssociationOrganization reporting that drug shortages pose a serious risk to patient safety.
  • governmentA governing system involved in managing the impact of supply disruptions.
  • European CommissionThe executive branch of the European Union involved in regulatory oversight.

Possible ripples

Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.

How it developed

Newest first. Tap a step to see who reported it.
  1. Shortage impact felt across Asia and Europe, with German manufacturer halting insulin supplies.1 source
  2. Bidafarma reported supply issues in Malaga, Spain on October 15, 2026.Sub-event
  3. A drug shortage in the Czech Republic has forced the use of an emergency EU allowance.Sub-event
  4. A supplier is reportedly withholding medicine from a government agency, causing market prices to rise due to supply shortages.Sub-event
  5. The European Medicines Agency noted production limitations for the drug Creon.Sub-event
  6. Europe faces widespread drug shortages due to production issues and high demand.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped